HPLE-LM SUGARS
LIVE

Serial Number

87571832

Owner

Pfanstiehl, Inc.

Attorney

Paul C. Llewellyn

First Use Date

May 1, 2020

Filing Date

Aug 16, 2017

Add to watchlist:

No watchlists yet
View on USPTO

HPLE-LM SUGARS Trademark

Serial Number: 87571832 • Registration: 6309239

HPLE-LM SUGARS is a trademark filed by Pfanstiehl, Inc. on August 16, 2017. The trademark is classified under Class 1 (Chemicals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Pfanstiehl, Inc. (32 trademarks)

Waukegan, IL 60085

Entity Type: 03

Trademark Details

Filing Date

August 16, 2017

Registration Date

March 30, 2021

First Use Anywhere

May 1, 2020

First Use in Commerce

May 1, 2020

Published for Opposition

July 3, 2018

Goods & Services

Biochemical research and development; Chemical, biochemical, biological and bacteriological research and analysis; Drug discovery services; Pharmaceutical drug development services; Product research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines and medicines

Chemicals and biochemicals for use in the formulation, development and manufacture of pharmaceuticals, biopharmaceuticals, vaccines, finished drug products, parenteral drugs and therapies; Chemicals and biochemicals for use in biotechnological product development and manufacturing processes; excipients and active ingredients for use in development, formulation and manufacture of pharmaceuticals, biopharmaceuticals, vaccines, injectable formulations, pharmaceutical intermediaries and drug formulations; chemicals, biochemicals, stabilizers, catalysts, enzymes, formulation ingredients, additives, drug delivery molecules and carriers, and buffers, all for use in the pharmaceutical and biopharmaceutical industry; active pharmaceutical ingredients for use in the manufacture of pharmaceuticals, biopharmaceuticals, vaccines, and finished drug products; formulation ingredients, additives, drug delivery molecules, and carriers, and buffers, all for use in the pharmaceutical and biopharmaceutical industry; pharmaceutical intermediates for use in the pharmaceutical and biopharmaceutical industry; biochemical excipients for use in the pharmaceutical and biopharmaceutical industry; biochemical catalysts; biochemical preservers and protectors for use in the pharmaceutical and biopharmaceutical industry

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 30, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
Mar 30, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 26, 2021 SUNA
SOU TEAS EXTENSION RECEIVED
Feb 25, 2021 EEXT
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 25, 2021 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jan 4, 2021 SUPC
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2020 EXRA
SOU EXTENSION 4 GRANTED
Sep 14, 2020 EX4G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 14, 2020 AITU
SOU EXTENSION 4 FILED
Aug 28, 2020 EXT4
SOU TEAS EXTENSION RECEIVED
Aug 28, 2020 EEXT
USE AMENDMENT FILED
Aug 23, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
Aug 23, 2020 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 27, 2020 EXRA
SOU EXTENSION 3 GRANTED
Feb 25, 2020 EX3G
SOU EXTENSION 3 FILED
Feb 25, 2020 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 25, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 29, 2019 EXRA
SOU EXTENSION 2 GRANTED
Aug 27, 2019 EX2G
SOU EXTENSION 2 FILED
Aug 27, 2019 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 27, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 27, 2019 EXRA
SOU EXTENSION 1 GRANTED
Feb 25, 2019 EX1G
SOU EXTENSION 1 FILED
Feb 25, 2019 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 25, 2019 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 28, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 3, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jul 3, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 13, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 29, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 16, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 16, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 16, 2018 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Nov 22, 2017 GPRN
PRIORITY ACTION E-MAILED
Nov 22, 2017 GPRA
PRIORITY ACTION WRITTEN
Nov 22, 2017 CPRA
ASSIGNED TO EXAMINER
Nov 18, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 24, 2017 NWOS
NEW APPLICATION ENTERED
Aug 21, 2017 NWAP